Delivery Order SPE2DB20D1100-SPE2DB25FD1W7
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a critical medical product, to support federal healthcare programs. The contract has a ceiling value of $4,101.77 and is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,081.84, is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product, with a completion date of November 7, 2024. The contract is a firm-fixed-price delivery order, and it is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,316.46 firm fixed-price contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML medical supplies. The contract has an ultimate completion date of March 14, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,072.44, is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. The contract is a Firm Fixed Price type and has an ultimate completion date of March 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE PEDIATRIC VIAL 5ML. The contract has a ceiling value of $16,121.10 and an ultimate completion date of August 5, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen has been a significant supplier of pharmaceutical products and medical supplies to various federal agencies, including...
- This is a federal contract award made by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product. The contract has a ceiling value of $11,605.35 and is a firm fixed price delivery order. It is not designated as a set-aside contract. The contract has an ultimate completion date of July 14,...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp., a major pharmaceutical distribution company, for the supply of INFUVITE PEDIATRIC VIAL 5ML medical products. The contract has a firm fixed price of $9,194.69 and a completion date of May 29, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE ADULT VIAL 10ML, a medical product. The contract has a ceiling value of $3,296.34 and is a firm fixed price contract. The ultimate completion date is July 1, 2025. The contract is not set aside and is open to full and open competition. Amerisourcebergen Drug Corp...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INFUVITE ADULT VIAL 10ML, a medical product, with a ceiling value of $6,413.18 and a period of performance through April 30, 2025. This contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has a ceiling value of $2,597.96 and a period of performance through May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD1W7Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product, with a period of performance through July 2, 2025 and a ceiling value of $20,090.52. The contract is structured as a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and there is no mention of any subcontractors. As a significant supplier to the federal government, particularly the Department of Defense and related healthcare programs, Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle through December 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.1k | 7/1/25 |